posaconazole and Diabetic-Ketoacidosis

posaconazole has been researched along with Diabetic-Ketoacidosis* in 1 studies

Other Studies

1 other study(ies) available for posaconazole and Diabetic-Ketoacidosis

Article	Year
Posaconazole mono- or combination therapy for treatment of murine zygomycosis. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:2 We compared the efficacy of combination posaconazole-liposomal amphotericin B (LAmB) therapy to monotherapy with either drug in diabetic ketoacidotic or neutropenic mice with disseminated zygomycosis caused by Rhizopus oryzae. Combination therapy was no better than LAmB alone, and posaconazole monotherapy did not improve survival or reduce fungal burden versus placebo. Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Diabetic Ketoacidosis; Dose-Response Relationship, Drug; Drug Combinations; Kidney; Liposomes; Male; Mice; Mice, Inbred BALB C; Neutropenia; Rhizopus; Triazoles; Zygomycosis	2009

Article

Year

Posaconazole mono- or combination therapy for treatment of murine zygomycosis.

Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:2

We compared the efficacy of combination posaconazole-liposomal amphotericin B (LAmB) therapy to monotherapy with either drug in diabetic ketoacidotic or neutropenic mice with disseminated zygomycosis caused by Rhizopus oryzae. Combination therapy was no better than LAmB alone, and posaconazole monotherapy did not improve survival or reduce fungal burden versus placebo.

Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Diabetic Ketoacidosis; Dose-Response Relationship, Drug; Drug Combinations; Kidney; Liposomes; Male; Mice; Mice, Inbred BALB C; Neutropenia; Rhizopus; Triazoles; Zygomycosis

2009